367 related articles for article (PubMed ID: 25009123)
1. The role of sphingosine-1-phosphate in endothelial barrier function.
Wilkerson BA; Argraves KM
Biochim Biophys Acta; 2014 Oct; 1841(10):1403-1412. PubMed ID: 25009123
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.
Wilkerson BA; Grass GD; Wing SB; Argraves WS; Argraves KM
J Biol Chem; 2012 Dec; 287(53):44645-53. PubMed ID: 23135269
[TBL] [Abstract][Full Text] [Related]
3. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial Phenotype.
Hansen L; Lohfink N; Vutukuri R; Kestner RI; Trautmann S; Hecht M; Wagner PV; Spitzer D; Khel MI; Macas J; Ferreirós N; Gurke R; Günther S; Pfeilschifter W; Devraj K
J Neurosci; 2022 Mar; 42(10):1908-1929. PubMed ID: 34903569
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-Phosphate and Atherosclerosis.
Kurano M; Yatomi Y
J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841
[TBL] [Abstract][Full Text] [Related]
6. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.
Argraves KM; Gazzolo PJ; Groh EM; Wilkerson BA; Matsuura BS; Twal WO; Hammad SM; Argraves WS
J Biol Chem; 2008 Sep; 283(36):25074-81. PubMed ID: 18606817
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative retinal neovascularization.
Niaudet C; Jung B; Kuo A; Swendeman S; Bull E; Seno T; Crocker R; Fu Z; Smith LEH; Hla T
EMBO Mol Med; 2023 May; 15(5):e16645. PubMed ID: 36912000
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein M: bridging HDL and endothelial function.
Christoffersen C; Nielsen LB
Curr Opin Lipidol; 2013 Aug; 24(4):295-300. PubMed ID: 23652568
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
Therond P; Chapman MJ
Curr Opin Lipidol; 2022 Jun; 33(3):199-207. PubMed ID: 35695616
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.
Tong X; Peng H; Liu D; Ji L; Niu C; Ren J; Pan B; Hu J; Zheng L; Huang Y
Cardiovasc Diabetol; 2013 Jan; 12():27. PubMed ID: 23360427
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363
[TBL] [Abstract][Full Text] [Related]
12. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
13. Barrier maintenance by S1P during inflammation and sepsis.
Ziegler AC; Gräler MH
Tissue Barriers; 2021 Oct; 9(4):1940069. PubMed ID: 34152926
[TBL] [Abstract][Full Text] [Related]
14. HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro.
Fan Y; Chen J; Liu D; Li W; Wang H; Huang Y; Gao C
Int J Biochem Cell Biol; 2020 Sep; 126():105819. PubMed ID: 32750426
[TBL] [Abstract][Full Text] [Related]
15. Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL).
Winkler MS; Märtz KB; Nierhaus A; Daum G; Schwedhelm E; Kluge S; Gräler MH
J Intensive Care; 2019; 7():23. PubMed ID: 31019718
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system.
Yao Mattisson I; Christoffersen C
Atherosclerosis; 2021 Oct; 334():76-84. PubMed ID: 34482091
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis?
Winkler MS; Nierhaus A; Poppe A; Greiwe G; Gräler MH; Daum G
Shock; 2017 Jun; 47(6):666-672. PubMed ID: 27922551
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Spns2 and ApoM Regulation of Vascular Tone and Hypertension Via Sphingosine-1-Phosphate.
Del Gaudio I; Rubinelli L; Sasset L; Wadsack C; Hla T; Di Lorenzo A
J Am Heart Assoc; 2021 Jul; 10(14):e021261. PubMed ID: 34240614
[TBL] [Abstract][Full Text] [Related]
19. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
Tong X; Lv P; Mathew AV; Liu D; Niu C; Wang Y; Ji L; Li J; Fu Z; Pan B; Pennathur S; Zheng L; Huang Y
Cardiovasc Diabetol; 2014 Apr; 13():82. PubMed ID: 24751283
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying the heterogeneous barrier responses of two primary endothelial cell types to sphingosine-1-phosphate.
Salminen AT; McCloskey MC; Ahmad SD; Romanick SS; Chen K; Houlihan W; Klaczko ME; Flax J; Waugh RE; McGrath JL
Eur J Cell Biol; 2022; 101(3):151233. PubMed ID: 35605366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
